Contact this trialFirst, we need to learn more about you.
Procedure
NEW Diabetes and Pain Medication Study
Recruiting0 awardsPhase 2
New York, New York
This trial will investigate whether a current hard gelatin capsule formulation of NRD135S.E1 is safe and effective in treating PDPN when taken once daily for 13 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.